Building a Robust Bioinformatics Infrastructure How streamlining RNA-seq data analysis facilitates groundbreaking Gene & Cell R&D Download customer story Quick, efficient scale-up of data-driven insights. A Cambridge-based company has dedicated …
Accelerate Biotech Innovation Impacts of Modern Transcriptomics Data Analytics Platforms Read the full case study Summary In the past decade, the groundwork has been established for researchers to leverage the …
9 factors you should consider when choosing RNA-seq analysis and visualization software Published on April 20th, 2023 by BigOmics ⏱ 11 min read Commercial RNA-seq data analysis software allows researchers, biotechnology, …
Omics data is becoming ubiquitous both in biological and, increasingly, medical research. Rapid developments in reagents, sequencing technologies and analysis are constantly pushing down costs while increasing the amount of …
Lugano, March 17, 2022 – BigOmics Analytics, a Swiss biodata analytics startup, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and …
Remix Therapeutics is a Boston-based biotechnology company developing novel small molecule therapies for reprogramming RNA processing and treating disease in entirely new ways. As protein targeting therapies reach the limits …
Bellinzona, Switzerland, December 10, 2021 – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will …
Part of the panic over the Coronavirus is due to not having vaccinated, for the founder of a start-up dedicated to the analysis of big data in the biomedical field …
With the advent of high-throughput ‘omics’ technologies, life scientists are starting to grapple with massive data sets. As Big Omics data continues to grow, biologists start encountering challenges with handling, …
The current Coronavirus epidemic (COVID-19) has been causing widespread panic and has been a major health concern in the past months. Efforts from both governments, pharmaceutical companies and the scientific …
